Gilder Gagnon Howe & Co’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.63M Sell
100,204
-344,092
-77% -$31.4M 0.1% 134
2026
Q1
$16.5M Buy
444,296
+126,348
+40% +$4.04M 0.2% 91
2025
Q4
$6.42M Sell
317,948
-6,092
-2% -$147K 0.07% 142
2025
Q3
$9.76M Buy
+324,040
New +$7.02M 0.1% 119

Other funds holding AEHR

Gilder Gagnon Howe & Co's AEHR Position: Q2 2026 in Review

Gilder Gagnon Howe & Co reduced its Aehr Test Systems (AEHR) stake by 77% in Q2 2026, selling an estimated $31.4M and leaving 100,204 shares worth $9.63M. The position accounts for 0.1% of the portfolio, ranked #134.

Gilder Gagnon Howe & Co first reported a position in AEHR in Q3 2025 and has held it in 4 quarters since. The position peaked at $16.5M in Q1 2026. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Gilder Gagnon Howe & Co held 100,204 shares of Aehr Test Systems worth $9.63M as of Q2 2026.
  • Gilder Gagnon Howe & Co sold 344,092 Aehr Test Systems shares in Q2 2026, an estimated $31.4M.
  • Aehr Test Systems made up 0.1% of Gilder Gagnon Howe & Co's portfolio in Q2 2026, its #134 holding.
  • Gilder Gagnon Howe & Co first reported a position in Aehr Test Systems in Q3 2025 and has held it in 4 quarters since.
  • Gilder Gagnon Howe & Co's Aehr Test Systems position peaked at $16.5M in Q1 2026.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2026, filed 14 Aug 2026.